Recovery from opioid use disorder can begin with a conversation, an appointment, or help after an overdose. You do not have to work out the entire path before asking for care—and treatment does not always mean moving into a residential rehab center.
This 2026 guide explains how to start, what medication treatment involves, how to choose a service, and what to expect at your first appointment. It also includes updated US overdose statistics, practical preparation advice, and ways to support someone you love.
The essentials
- Opioid use disorder is treatable. Medication, medical care, and support can help people build a life in recovery.
- Ask about medication at the first contact. Buprenorphine, methadone, and naltrexone are the three FDA-approved medications for opioid use disorder.
- Detox alone is not a complete treatment plan. Continuing care and overdose prevention matter after withdrawal symptoms improve.
- Keep naloxone available. People with opioid use disorder and those close to them should know how to recognize and respond to an overdose.
Explore this guide
How to get help today
You can ask a primary care clinician, community health center, addiction-medicine service, or an opioid treatment program for an assessment. If you are already receiving emergency or hospital care, ask whether treatment can begin there and how follow-up will be arranged.
Make a specific request
Try: “I’m concerned about my opioid use and want an assessment for opioid use disorder. Do you offer medication treatment, and how soon can I be seen?” You can ask about help even if you are unsure whether “addiction” describes your situation.
Find a service that offers the care you need
Search FindTreatment.gov or use SAMHSA’s National Helpline, 1-800-662-4357. It provides free, confidential treatment-referral information 24 hours a day in English and Spanish. Ask specifically about opioid medication treatment, your insurance, and low-cost options.
Ask what to do while waiting
Find out whether there is an earlier assessment, another clinic, or a same-day service. Tell staff about current withdrawal, recent overdose, pregnancy, and other substance use. Do not try to design your own medication-starting or detox schedule from a general article.
Make an overdose-response plan
Ask a pharmacist, clinician, or local health department how to obtain naloxone and learn to use it. Make sure someone you trust knows where it is. If symptoms are urgent, seek medical care rather than waiting for a routine intake appointment.
Some services offer telehealth, while others need an in-person assessment or regular visits. Confirm the current requirements, pharmacy arrangements, and what happens if you cannot make an appointment. Practical access is part of choosing a treatment plan you can maintain.
What is opioid use disorder?
Opioid use disorder, or OUD, is a medical condition involving a problematic pattern of opioid use that causes significant distress or difficulty in daily life. It can involve prescription pain medicines, heroin, fentanyl, or other opioids. A person’s appearance, job, income, or family circumstances cannot establish the diagnosis.
Concerns worth discussing with a clinician include using more than intended, repeated unsuccessful attempts to cut down, strong cravings, spending substantial time obtaining or recovering from opioids, and continued use despite harm to health or responsibilities. CDC’s diagnostic guidance uses a clinical assessment of symptoms over a 12-month period.
Physical dependence is not the same as addiction
Someone taking prescribed opioids can develop tolerance or withdrawal without having OUD. CDC specifically notes that those two diagnostic criteria do not count when opioids are taken solely under appropriate medical supervision. Do not abruptly change a prescribed pain regimen on the basis of a checklist; speak with the prescriber about pain, side effects, dependence, and any concerns about control over use.
For families, missed appointments, withdrawal from relationships, or unusual drowsiness can be reasons to ask what is happening. They are not proof of opioid use disorder. Focus on specific observations and safety, and encourage a professional assessment.
Medication is a central treatment option
FDA identifies three approved medications for OUD: buprenorphine, methadone, and naltrexone. They work differently. The best choice depends on your medical history, current opioid use, preferences, previous treatment, and access to follow-up.
Buprenorphine
What it does: Reduces withdrawal symptoms and cravings. It is a partial opioid agonist, meaning it activates opioid receptors differently from a full agonist such as methadone.
Where care happens: Office-based and other clinical settings, with formulations that include dissolving products and long-acting injections. Ask which options the service actually offers and how prescriptions are filled.
What to discuss: Starting it at the wrong point after other opioid use can trigger sudden withdrawal. Your clinician should give an individualized initiation plan, particularly when fentanyl may be involved. SAMHSA’s buprenorphine overview explains the treatment and safety considerations.
Methadone
What it does: Reduces opioid withdrawal and cravings. It is a full opioid agonist used in a structured treatment plan.
Where care happens: For ongoing OUD treatment, methadone is generally dispensed through a certified opioid treatment program. Ask about the initial visit schedule, transport, take-home eligibility, and how care continues during travel or a move.
What to discuss: Medication interactions, sedation, other health conditions, and how the program monitors safety and adjusts treatment. SAMHSA describes methadone treatment and program requirements.
Naltrexone
What it does: Blocks opioid effects rather than activating opioid receptors. An extended-release injection is one treatment option.
Where care happens: A prescribing clinician can provide or arrange treatment. Access to follow-up injections and insurance coverage should be checked in advance.
What to discuss: An opioid-free interval is required before starting, and the clinician must determine when it is safe. Starting too soon can cause severe withdrawal. Discuss pain-treatment needs and overdose risk if treatment is interrupted. SAMHSA’s naltrexone guidance explains these precautions.
You do not need to “earn” medication by completing counseling
Counseling can help with coping skills, relationships, mental health, and recovery goals. But CDC advises that unavailable or declined psychosocial treatment should not delay medication for OUD. Ask about both, rather than assuming one must be completed before the other.
The separate federal buprenorphine “X-waiver” is no longer required. SAMHSA explains that practitioners with appropriate DEA registration can prescribe buprenorphine for OUD, subject to applicable state law. An individual practice may still not offer it, so ask directly.
Updated opioid overdose statistics
Final CDC data recorded 54,045 overdose deaths involving opioids in 2024, compared with 79,358 in 2023. The age-adjusted rate fell from 24.0 to 16.0 deaths per 100,000 standard population. These figures come from NCHS Data Brief 549, published in January 2026.
United States · final 2023–2024 data
Overdose deaths involving opioids declined in 2024
Compare the number of deaths with the age-adjusted rate, which accounts for differences in population age structure.
Age-adjusted deaths per 100,000 standard population
View the data and source notes
| Opioid category | 2023 deaths | 2024 deaths | 2023 rate | 2024 rate |
|---|---|---|---|---|
| Any opioid | 79,358 | 54,045 | 24.0 | 16.0 |
| Synthetic opioids other than methadone | 72,776 | 47,735 | 22.2 | 14.3 |
| Natural and semisynthetic opioids | 10,112 | 7,989 | 2.9 | 2.3 |
| Heroin | 3,984 | 2,743 | 1.2 | 0.8 |
Rates are deaths per 100,000 standard population, adjusted to the 2000 US standard population. Counts and rates are transcribed from the same final report; provisional rolling estimates are not mixed in. Methadone-specific deaths are not shown separately, but are included in “Any opioid.” A death may involve several drugs. Download the data (CSV).
The decline is encouraging, but these are national mortality statistics, not a measure of an individual’s chance of recovery. They do not establish why deaths fell or how effective a particular program is. Continuing access to treatment and overdose-reversal medication remains essential.
How to choose the right treatment setting
A beach, a private room, or a long packing list tells you little about the clinical care. Start by asking whether a service can assess OUD, offer or coordinate appropriate medication, manage other health conditions, and provide a workable follow-up plan.
- Office-based outpatient care
- Appointments while living at home, potentially combining medication, counseling, and other medical care. Ask about visit frequency, pharmacy access, and urgent concerns between appointments.
- Opioid treatment program
- A specialized service that can provide methadone and other OUD care. Check its medication options, appointment schedule, and arrangements for take-home doses.
- Intensive outpatient or day treatment
- More structured clinical contact while living elsewhere. Confirm how medication is provided and whether transport or recovery housing is separate.
- Residential or hospital care
- Residential programs provide a place to live with structured treatment. Hospital inpatient care addresses needs requiring a hospital setting. Ask how existing medication will continue and what happens after discharge.
A clinical assessment should guide the level of care. Severe medical symptoms, unsafe living circumstances, or complex co-occurring conditions may change what support is needed. Outpatient care is not simply for people who are “less serious” about recovery, and a residential stay is not the only route to treatment.
Five questions for the admissions team
- Medication
- Can you start or continue buprenorphine or methadone, or coordinate with a service that does?
- Medical support
- Who manages withdrawal, medications, pain, and mental health concerns?
- The first week
- What appointments will I attend, and how much travel is involved?
- Costs and coverage
- What are the full costs? Is this location and level of care covered by my insurance?
- Continuing care
- Who provides my next appointment and medication after discharge or a transfer?
Marketplace plans cover substance use disorder treatment, but network, authorization, and cost-sharing rules still apply. If paying yourself, ask about income-based fees and financial assistance. Get a written estimate rather than relying on “we accept insurance.”
What happens at the first appointment?
The assessment should help you and the clinician agree on a safe, realistic starting plan. Be as accurate as you can about substances, last use, medications, and previous experiences; these details can change treatment decisions. If something feels hard to disclose, say that and ask about confidentiality.
- Current opioid use
- What you take, how you take it, when you last used it, and whether fentanyl or an unknown substance may be involved.
- Medicines and other substances
- Include alcohol, benzodiazepines, sleep medicines, prescribed treatments, and nonprescription products.
- Health and safety
- Mention withdrawal, previous overdose, pain, breathing problems, pregnancy, and mental health concerns.
- Previous treatment
- Explain what helped, side effects, why care ended, and your medication preferences.
- Daily life
- Discuss housing, transport, work, caregiving, insurance, and access to a phone or pharmacy.
- Your priorities
- Bring questions and explain what you most want help with, such as cravings, sleep, or staying connected to care.
The clinician may assess withdrawal, review medical history, perform an examination, or recommend testing. Ask what each test is for and how the result will affect care. Depending on the assessment and setting, treatment may start that day or require a specific next step.
Leave with a clear next step
Before the appointment ends, make sure you know what the treatment plan is, who to contact with symptoms or side effects, how to obtain any prescribed medication, and when the next visit will occur. If a pharmacy cannot fill a prescription or a referral has a waiting list, contact the treating team promptly.
If you use alcohol or sedatives alongside opioids, tell the clinician. Combining these substances can increase overdose risk. CDC advises against withholding buprenorphine or methadone for OUD from people taking benzodiazepines. Do not abruptly stop a prescribed sedative on your own.
Preparing for treatment—and packing if you will stay overnight
If you are entering a residential program, a little preparation can make arrival easier. Many people, however, begin OUD treatment through outpatient appointments and do not need to pack for a stay. For any setting, prioritize your medication list, health information, contact details, and a way to attend the next appointment.
For a residential stay
Get the program’s current written packing list and ask about items you cannot easily replace. Rules on devices, toiletries, tobacco products, personal belongings, and visitors vary; avoid buying special supplies until you have checked.
Bring
- Identification and insurance details if available; a medication list, allergies, and medical contacts. If documents are missing, ask how intake can proceed.
- Comfortable clothes, sleepwear, footwear, and toiletries approved by the program.
- Important phone numbers on paper and a few permitted personal items. Leave unnecessary valuables at home.
Confirm
- How to bring and store prescribed medicines, and how OUD medication will continue. Do not stop treatment based on an assumed admission rule.
- Device, toiletries, and belongings policies before buying supplies.
- Laundry access, storage space, and how family can contact you.
Arrange
- Transport to treatment and the next appointment.
- Care for children or dependents, and a plan for work and bills.
- A contact for practical support and help with unexpected problems.
Ask about privacy and communication
Confirm phone and laptop rules, how family can reach you, and how urgent work or caregiving issues are handled. Ask what happens to belongings that are restricted, whether a bag check is part of admission, and how to raise a concern about your care. Policies should be explained rather than assumed.
How to help someone you love
Choose a calm moment when the person can participate in the conversation. Describe what you have noticed, explain your concern, and offer a concrete next step. Avoid turning a difficult conversation into a debate over whether someone is “an addict.”
“I’m worried because you’ve seemed very drowsy and missed things that matter to you. I care about you. Would you be willing to call a clinician with me and ask about treatment?”
You can offer a ride, help locate a clinic, join a call with permission, or help with childcare. Ask what would make the first step easier. If they decline, you can keep the conversation open, maintain boundaries around your own safety, and still learn how to respond to an overdose.
CDC encourages supportive, nonjudgmental involvement and recognizes medication as part of recovery. Taking prescribed methadone or buprenorphine is not a reason to dismiss someone’s progress. Do not pressure a family member to stop medication to prove they are “really recovered.”
Supporting another person does not mean managing every appointment or accepting threats or violence. Seek support for yourself, discuss boundaries, and involve professionals when safety or medical decisions are at stake. In an overdose emergency, act immediately rather than waiting for agreement about treatment.
Recovery continues after the first appointment or discharge
Early progress may mean fewer cravings, more stable sleep, attending appointments, or reconnecting with everyday responsibilities. A useful care plan also addresses pain, mental health, housing, relationships, and employment where needed. Recovery is more than completing an admission or passing a single test.
Detox is not a substitute for ongoing treatment
CDC does not recommend detoxification alone for OUD because of the increased risks of returning to use, overdose, and death. Reduced tolerance after time away from opioids can make a return to a previously used amount dangerous. Ask for medication options, follow-up, and naloxone before leaving care.
If opioid use returns, reconnect promptly
Tell the treating team what happened so they can reassess medication, support, and immediate safety. A return to use is a reason to review the plan, not proof that care cannot work. Seek urgent help if overdose or severe symptoms are possible, and do not independently restart or adjust medication after an interruption.
Plan for transitions before they happen
Discharge, a move, a new insurer, or release from a correctional setting can interrupt care. Confirm the next clinician or program, an appointment date, medication arrangements, and who will handle records or authorizations. Discuss any decision to taper with the prescriber; treatment length should follow your needs rather than an arbitrary deadline.
Frequently asked questions
Do I have to enter residential rehab to recover?
No. Opioid treatment can take place in different settings, including outpatient care. The decision should account for medical needs, current symptoms, safety at home, and the support you can access. Ask whether the setting can provide the medication and follow-up you need instead of treating an overnight stay as the definition of recovery.
Is buprenorphine or methadone just replacing one addiction with another?
Physical dependence and addiction are different. In a supervised treatment plan, these medications help control withdrawal and cravings so people can function and work toward recovery. MedlinePlus explains why medication treatment is not simply substituting addictions. Discuss side effects, monitoring, and goals with the prescriber rather than stopping because of stigma.
How long will opioid treatment take?
There is no universal 28-day or 90-day endpoint. Withdrawal management, stabilization, and longer-term recovery are different parts of care. SAMHSA notes that buprenorphine treatment can be tailored and may continue indefinitely. Review progress and treatment duration with your clinician; continued medication can be part of successful recovery.
Can I start treatment if fentanyl may be involved?
Yes—tell the clinician about known or possible fentanyl use and your last use. It can affect how medication is started and monitored. In particular, buprenorphine must be initiated carefully to avoid precipitated withdrawal. Do not use a fixed internet waiting period or someone else’s medication plan as a substitute for clinical guidance.
Are naloxone and naltrexone the same thing?
No. Naloxone is an emergency opioid-overdose reversal medication. Naltrexone is a medication used in an ongoing treatment plan and is not an overdose rescue medicine. Keep the prescribed or supplied naloxone rescue product accessible and learn its instructions; do not assume another medicine with a similar name will work in an emergency.
What if I am pregnant or might become pregnant?
Contact an obstetric and addiction-treatment clinician promptly. CDC describes methadone and buprenorphine as recommended treatment options during pregnancy, alongside appropriate medical and behavioral care. Do not abruptly stop opioids or OUD medication on your own. A coordinated plan should address your health, pregnancy care, medication, and support after delivery.
What if I cannot afford treatment?
Ask about Medicaid participation, a sliding fee scale, and publicly funded services. SAMHSA lists ways to find free or reduced-cost treatment, including health centers and financial assistance. Explain your financial situation at the first call and ask about eligibility and waiting lists. Our price guide above explains what insurance changes and which charges to check.
Does someone still need an ambulance after naloxone works?
Yes. Call 911 and stay with the person even if they wake up. Opioid effects can return after naloxone wears off, and further treatment may be needed. CDC’s response guidance explains that another dose may be needed if normal breathing has not returned after 2–3 minutes. Follow the product instructions and emergency dispatcher’s directions.
Updated September 12, 2026. The chart uses final US mortality data for 2023–2024, published by CDC/NCHS in January 2026; it does not present provisional 2025–2026 estimates as final figures. Medical and treatment-access sources are linked within the relevant sections.